VS-6063
Showing 1 - 25 of >10,000
Low Grade Serous Ovarian Cancer Trial (avutometinib + defactinib, Investigator Choice of Treatment (ICT))
Not yet recruiting
- Low Grade Serous Ovarian Cancer
- avutometinib + defactinib
- Investigator Choice of Treatment (ICT)
- (no location specified)
Oct 2, 2023
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Defactinib
Active, not recruiting
- Advanced Lymphoma
- +5 more
- Defactinib Hydrochloride
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 28, 2022
Ovarian Cancer Trial in San Diego (VS-6063, Paclitaxel, Carboplatin)
Recruiting
- Ovarian Cancer
- VS-6063
- +2 more
-
San Diego, CaliforniaUniversity of California San Diego
Feb 1, 2023
Metastatic Uveal Melanoma Trial in Philadelphia (Defactinib Hydrochloride, Raf/MEK Inhibitor VS-6766)
Recruiting
- Metastatic Uveal Melanoma
- Defactinib Hydrochloride
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023
MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Sydney (Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET,
Recruiting
- Myelodysplastic Syndromes
- +2 more
- Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET
- Defactinib
-
Sydney, New South Wales, Australia
- +3 more
Jan 12, 2023
NSCLC, Low Grade Serous Ovarian Cancer, Endometrioid Carcinoma Trial in United Kingdom (VS-6766, Defactinib)
Recruiting
- NSCLC
- +3 more
-
Manchester, Greater Manchester, United Kingdom
- +4 more
Mar 18, 2022
Malignant Pleural Mesothelioma Trial in Boston (VS-6063)
Terminated
- Malignant Pleural Mesothelioma
- VS-6063
-
Boston, MassachusettsBrigham and Women's Hospital
May 13, 2021
Pancreas Cancer, Cancer of the Pancreas, Pancreas Adenocarcinoma Trial in Saint Louis (device, drug, procedure)
Recruiting
- Pancreas Cancer
- +2 more
- MR-guided stereotactic body radiation therapy
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 29, 2023
Advanced Solid Tumors, Solid Tumors, Pancreatic Cancer Trial in Rochester, Saint Louis (Defactinib, Pembrolizumab, Gemcitabine)
Completed
- Advanced Solid Tumors
- +2 more
- Defactinib
- +2 more
-
Rochester, Minnesota
- +1 more
Jul 18, 2021
Non Small Cell Lung Cancer, KRAS Activating Mutation Trial in Worldwide (VS-6766, VS-6766 and Defactinib)
Recruiting
- Non Small Cell Lung Cancer
- KRAS Activating Mutation
- avutometinib (VS-6766)
- avutometinib (VS-6766) and Defactinib
-
Duarte, California
- +44 more
Dec 22, 2022
Ovarian Cancer Trial in Worldwide (VS-6766, VS-6766 and Defactinib)
Recruiting
- Low Grade Ovarian Serous Adenocarcinoma
- Ovarian Cancer
- avutometinib (VS-6766)
- avutometinib (VS-6766) and Defactinib
-
Scottsdale, Arizona
- +46 more
Dec 29, 2022
Epithelial Ovarian Cancer Trial in United States (Part A - VS-6063, Part A - Avelumab)
Terminated
- Epithelial Ovarian Cancer
- Part A - VS-6063
- Part A - Avelumab
-
Sarasota, Florida
- +4 more
Apr 28, 2019
Suicide, Suicide Prevention, Suicide and Self-harm Trial in Boise (Caring Contacts)
Not yet recruiting
- Suicide
- +2 more
- Caring Contacts
-
Boise, IdahoSt. Luke's Health System
Nov 10, 2023
Myopia Trial in Ho Chi Minh City (Myatro, Myatro XL)
Not yet recruiting
- Myopia
- Myatro
- Myatro XL
-
Ho Chi Minh City, VietnamUniversity Medical Center HCMC
Apr 5, 2023
Living-Kidney Donors Trial in Cologne (Fasting mimicking diet, Ketogenic diet, Dietary restriction of sulfur containing amino
Not yet recruiting
- Living-Kidney Donors
- Fasting mimicking diet
- +3 more
-
Cologne, GermanyDepartment II of Internal Medicine, Center for Molecular Medicin
Feb 2, 2023
Stroke Trial in Irvine (Split belt treadmill, Biofeedback)
Recruiting
- Stroke
- Split belt treadmill
- Biofeedback
-
Irvine, CaliforniaChapman University
Sep 11, 2023
Healthy, Men, Adults Trial in Brussels (Cycling exercise, Cycling control)
Recruiting
- Healthy
- +2 more
- Cycling exercise
- Cycling control
-
Brussels, BelgiumInstitute of Neuroscience, UCLouvain
Jul 17, 2023
Lateral Epicondylitis, Rotator Cuff Syndrome Trial in Taipei (combination product, other, drug)
Recruiting
- Lateral Epicondylitis
- Rotator Cuff Syndrome
- lyophilized platelet (30ng) and triamcinolone acetonide 10mg
- +2 more
-
Taipei, TaiwanNational Taiwan University Hospital
Dec 12, 2022
Heart Failure NYHA Class III, Heart Failure NYHA Class IV, Chronic Illness Trial (UPHOLDS (Utilizing Palliative Care for Heart
Not yet recruiting
- Heart Failure NYHA Class III
- +2 more
- UPHOLDS (Utilizing Palliative Care for Heart Failure Optimized using Lay Navigators to Decrease Suffering)
- (no location specified)
May 18, 2023
Systemic Lupus Erythematosus (Sle) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Nicotinamide Riboside)
Not yet recruiting
- Systemic Lupus Erythematosus (Sle)
- Nicotinamide Riboside
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 15, 2023
Lack of Keratinized Gingiva Trial in Lexington (L-PRF (Leucocyte- platelet rich fibrin), H-PRF (Horizontal -platelet rich
Recruiting
- Lack of Keratinized Gingiva
- L-PRF (Leucocyte- platelet rich fibrin)
- +2 more
-
Lexington, KentuckyUniversity of Kentucky
Jan 23, 2023
Knee Osteoarthritis Trial in Tacoma (other, biological, device)
Recruiting
- Knee Osteoarthritis
- Physical Therapy
- +2 more
-
Tacoma, WashingtonMadigan Army Medical Center
Nov 2, 2023
Gonarthrosis Trial in Istanbul (Exercise, Topical Diclofenac, Platelet-Rich-Plasma (PRP))
Not yet recruiting
- Gonarthrosis
- Exercise
- +2 more
-
Istanbul, TurkeyIstanbul University-Cerrahpasa
May 17, 2023
Coronary Artery Disease, Aortic Valve Disease Trial in Copenhagen (Tocilizumab, Isotonic sodium chloride (0.9%), Dexamethasone
Recruiting
- Coronary Artery Disease
- Aortic Valve Disease
- Tocilizumab
- +8 more
-
Copenhagen, DenmarkThe Heart Centre, Rigshospitalet
Nov 29, 2022